Karyopharm hides death rate tied to cancer drug, dimming approval hopes

Karyopharm hides death rate tied to cancer drug, dimming approval hopes

STAT Plus: Karyopharm hides higher death rate tied to blood cancer drug, dimming approval hopes

By ADAM FEUERSTEIN

The higher death rate was not revealed until the FDA disclosed it as part of a skeptical review that could stop the drug from reaching the market.

READ MORE